Clínic Barcelona

Clínic-IDIBAPS, a key role in developing the Hipra vaccine

The HIPRA vaccine against COVID-19 is the first vaccine authorised for human health that has been designed and developed in Spain, and various services and units from both the Hospital Clínic Barcelona and IDIBAPS have played a determining role in its development.  

Related contents
Keep reading about: